Concepedia

Value of 18F-FDG PET/CT in detecting viable tumour and predicting prognosis of hepatocellular carcinoma after TACE

H.-J. Song, Jingyi Cheng, S.-L. Hu, Guojun ZHANG, Yali Fu, Y.-J. Zhang

Clinical Radiology · 2014 · 36 citations · 27 references

DOIFull text

Open access

Concepts

References

27

Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL Conference

Jordi Bruix, Morris Sherman, Josep M. Llovet et al. · Journal of Hepatology · 2001 · 4.1K citations

, , +16

Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial

Josep M. Llovet, María Isabel Real, Xavier Montañá et al. · The Lancet · 2002 · 3.5K citations

, , +16

Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma

Chung‐Mau Lo, Wai‐Kuen Tso, Chi‐Leung Liu et al. · Hepatology · 2002 · 2.6K citations · Full text

, , +16

Hepatocellular Carcinoma Incidence, Mortality, and Survival Trends in the United States From 1975 to 2005

Sean F. Altekruse, Katherine A. McGlynn, Marsha E. Reichman · Journal of Clinical Oncology · 2009 · 1.7K citations · Full text

, , +16

In vivo assessment of glucose metabolism in hepatocellular carcinoma with FDG-PET.

Tatsuo Torizuka, Nagara Tamaki, Tetsuro Inokuma et al. · PubMed · 1995 · 360 citations

, , +17